drug - International Pharmaceutical Industry

Volume 15 Issue 3

Antibody Drug Conjugates and the Link to Fighting Cancer

Antibody drug conjugates (ADCs) are a big deal in oncology. And rightly so: they combine highly specific targeting with a potent cytotoxic payload to deliver tremend...

29 September 2023 Volume 15 Issue 3 ADCs | antibody

Continue Reading →

Volume 15 Issue 3

High Potent Manufacture

The global market for drug products containing highly potent active pharmaceutical ingredients (HPAPIs) is currently on a growth fast track. Data indicates a Compoun...

29 September 2023 Volume 15 Issue 3 active | drug

Continue Reading →

Volume 15 Issue 3

Addressing the Challenges of Serialisation

Drug counterfeiting poses a significant threat to the pharmaceutical industry, risking patient safety and undermining the integrity of the global supply chain. As il...

29 September 2023 Volume 15 Issue 3 Addressing | chain

Continue Reading →

Volume 15 Issue 3

Chemical Recycled ABS Materials for the Transition to a Circular Economy Model

The demand for new, sustainable ABS materials for drug delivery device applications is growing in the healthcare sector. However, because of the risk of cross-contam...

29 September 2023 Volume 15 Issue 3 ABS | applications

Continue Reading →

Volume 15 Issue 2

Unlocking the Potential of Drug Discovery Labs with Automation

Trying to achieve more without increasing costs, sacrificing quality, or slowing down growth is a constant mission for any expanding business or industry – but it is...

3 July 2023 Volume 15 Issue 2 achieve | automation

Continue Reading →

Volume 15 Issue 2

Potent Product Manufacturing in a Multi-product Facility

Highly potent drugs are becoming increasingly common in the drug development pipeline. The focus on oncology, rare diseases, and targeted therapies is grow...

3 July 2023 Volume 15 Issue 2 development | drug

Continue Reading →

Volume 15 Issue 2

Effective Operations for Risk Reduction and Supply Chain Resilience

There is no denying that the market for injectable drug delivery devices is growing rapidly, with forecasts predicting an increase from $39.93 billion in 2022 to $43...

3 July 2023 Volume 15 Issue 2 chain | delivery

Continue Reading →

Volume 15 Issue 1

Fulfilling the Potential of Drug R&D: Six Predictions for 2023

From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that e...

4 April 2023 Volume 15 Issue 1 clinical | development

Continue Reading →

Volume 15 Issue 1

How to Take a Safety-first Approach When Harnessing the Power of HPAPIs

In this article, Mike Avraam at ChargePoint Technology explores the challenges of handling HPAPIs safely and discusses how to comply with safety regulations. He expl...

4 April 2023 Volume 15 Issue 1 diabetes | drug

Continue Reading →

News

Bankrupt Zosano sells intradermal delivery tech to Emergex Vaccines

The unraveling of Zosano Pharma has led to a drug delivery deal. With the company filing for bankruptcy in the wake of its rejection by the FDA, Emergex Vaccines has...

19 October 2022 News biopharmaceutical | biopharmaceutical industries

Continue Reading →